Federico Navarro Sarabia

Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

J.V. Pérez-Moreiras, Juan J. Gómez‐Reino, José Ramón Maneiro et al. · American Journal of Ophthalmology · 2018 · 288 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

Charles Peterfy, Paul Emery, Paul P. Tak et al. · Annals of the Rheumatic Diseases · 2014 · 59 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis

M. Perez Busquier, Enrique Calero, Manuel Rodríguez Rodríguez et al. · Clinical Rheumatology · 1997 · 41 citations

Medicine, Clinical Pharmacy, Pharmacotherapy +8

Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score)

Charles Peterfy, Paul Emery, P. P. Tak et al. · Research at the University of Copenhagen (University of Copenhagen) · 2011 · 18 citations

Medicine, Immunology, Pharmacotherapy +16

Disease-modifying antirheumatic drug prescription patterns in adult rheumatoid arthritis patients in routine clinical practice in Spain

Blanca Hernández‐Cruz, Inmaculada Ureña‐Garnica, Ricardo Sánchez Parera et al. · European Journal of Rheumatology · 2020 · 13 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13